Home » Topics » BioWorld Science

BioWorld Science
RSS

Aurigene's small molecule antagonist targets both PD-L1 and TIGIT pathways

Nov. 20, 2018

Nash Pharmaceuticals reports data on NP-135 in mouse model of kidney fibrosis

Nov. 20, 2018

SNACing on peptides: findings may allow oral delivery of peptides

Nov. 20, 2018

NLRP3 antagonist IFM-514 shows promise in mouse models of NASH

Nov. 20, 2018

Immunocore and Genentech enter partnership to codevelop IMC-C103C

Nov. 20, 2018

NOXA gives leg up to BCL-2 inhibition

Nov. 20, 2018

Sleeper HIV can be napping or conked out

Nov. 20, 2018

New type of neuronal insulation discovered

Nov. 20, 2018

Identification and preclinical characterization of ABX-1431, inhibitor of monoacylglycerol lipase

Nov. 20, 2018

Merck KGaA and Pfizer provide update on JAVELIN ovarian cancer program of avelumab

Nov. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026